Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

LLY vs MRK: stock comparison and AI forecast

Eli Lilly & Co (LLY) and Merck & Co., Inc. (MRK) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
NYSE · Pharmaceutical Preparations

LLY Eli Lilly & Co

Price
$1364.73 +40.0% · 6M
Market Cap
$1.28T
P/E Ratio
44.3x
Size
mega-cap
AI Forecast
Full analysis →
NYSE · Pharmaceutical Preparations

MRK Merck & Co., Inc.

Price
$146.73 +30.7% · 6M
Market Cap
$362.01B
P/E Ratio
151.3x
Size
mega-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-11-06

Six-month price performance

Closing prices rebased to 100 at the start of the window.

100110120130140
LLY +40.0% MRK +30.7%
LLY · MRK

Key facts

  • LLY is 3.5 times larger than MRK by market capitalization ($1.28T against $362.01B).
  • LLY trades at 44.3 times trailing earnings, MRK at 151.3 times.
  • Over the last six months LLY returned +40.0% and MRK +30.7%.
  • LLY carries 3.36 times debt per unit of equity, against 1.96 times for MRK.
  • MRK yields 2.31% in dividends and LLY 0.47%.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricLLYMRK
Market Cap$1.28T$362.01B
P/E Ratio44.29x151.27x
P/B Ratio130.62x8.06x
Dividend Yield0.47%2.31%
EPS$30.81$0.97
Book Value/Share$10.45$18.20
Revenue/Share$91.91$27.31
FCF/Share–$5.98

Profitability & Margins

MetricLLYMRK
ROE–5.5%
ROA–1.9%
Gross Margin83.6%71.8%
Net Margin–3.6%
EBT Margin135.0%7.1%
Tax Rate20.7%48.5%

Financial Health

MetricLLYMRK
Current Ratio1.39x1.35x
Quick Ratio1.00x1.14x
D/E Ratio3.36x1.96x
Financial Leverage–2.96x
Working Capital$18.27B$10.14B

Cash Flow

MetricLLYMRK
Operating Cash Flow$30.64B$18.70B
Free Cash Flow–$14.75B
Capital Spending–-$3.96B
OCF Growth YoY90.8%9.6%
FCF Growth YoY–13.0%
FCF/Sales–21.9%
CapEx/Sales–5.9%

Operational Efficiency

MetricLLYMRK
Asset Turnover–0.51x
Receivables Turnover3.9x5.3x
Inventory Turnover0.8x3.1x
Fixed Assets Turnover2.7x2.6x
Days Sales Outstanding93 days69 days
Days Inventory469 days118 days
Payables Period149 days96 days
Cash Conversion Cycle413 days91 days

Income Statement

MetricLLYMRK
Total Revenue$86.46B$67.38B
Net Income–$2.45B
R&D Expense$15.38B$30.76B
SG&A Expense$12.62B$11.39B
Cost of Goods Sold$14.15B$19.03B

Dividend & Shareholder Information

MetricLLYMRK
Dividends Per Share$6.36$3.39
Payout Ratio20.6%349.5%
Shares Outstanding941M2467M
Net Income Growth–-87.1%
EPS Growth50.7%-87.2%
FAQ

LLY vs MRK: stock comparison and AI forecast

Which is bigger, LLY or MRK?

LLY is 3.5 times larger than MRK by market capitalization ($1.28T against $362.01B).

Which is cheaper on earnings, LLY or MRK?

LLY trades at 44.3 times trailing earnings, MRK at 151.3 times.

Which stock performed better over the last six months, LLY or MRK?

Over the last six months LLY returned +40.0% and MRK +30.7%.

Which one does Intratio's AI model rank higher, LLY or MRK?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.